Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
7 NC counties are under alert, including Johnston County.
Program
On WRAL at 6: Hidden fees in your childâs school lunch payment ð¨ð¸ 5 On Your Side shows you how to keep more money in your pocket
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bridgebio Pharma Inc
(NQ:
BBIO
)
25.66
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bridgebio Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
March 07, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
4 Analysts Have This to Say About BridgeBio Pharma
March 07, 2023
Via
Benzinga
Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors' Attention Today
March 06, 2023
Via
Benzinga
Why Is BridgeBio Pharma (BBIO) Stock Up 60% Today?
March 06, 2023
BBIO stock looks unstoppable today as BridgeBio Pharma diligently advances a treatment for a rare and unfortunate condition.
Via
InvestorPlace
Looking Into BridgeBio Pharma's Return On Capital Employed
February 28, 2023
Via
Benzinga
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
March 06, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
Why BioMarin Shares Are Plunging Today?
March 06, 2023
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.
Via
Benzinga
These 2 Biotech Stocks Made Big Monday Moves
March 06, 2023
Find out which was the winner and which was the loser.
Via
The Motley Fool
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
March 06, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P...
Via
Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 06, 2023
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
Via
Benzinga
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
March 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500...
Via
Benzinga
Why BridgeBio Pharma Stock Is Skyrocketing Today
March 06, 2023
BridgeBio's latest results could set the bar in efficacy for treating the most common cause of short stature.
Via
The Motley Fool
Stocks Rise As Bond Yields Fall; Investors Await Economic Data
March 06, 2023
Wall Street is starting the week higher, as investors look ahead to upcoming economic data and new commentary from the Federal Reserve.
Via
Talk Markets
BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile
March 06, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the...
Via
Benzinga
What's Going On With Kala Pharmaceuticals Shares Today
March 06, 2023
Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the...
Via
Benzinga
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
March 06, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
What's Going On With Avalon GloboCare Shares Today
March 06, 2023
The overall market ticked slightly higher in pre-market trading Monday morning, but Avalon Globocare Corp (NASDAQ: ALBT) shares really took off. Avalon GloboCare is a biotech company headquartered in...
Via
Benzinga
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January
March 06, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose...
Via
Benzinga
BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study
March 06, 2023
The company is testing a drug for children with achondroplasia, a cause of dwarfism.
Via
Investor's Business Daily
Why BridgeBio Pharma Stock Is Hitting New 52-Week Highs Monday
March 06, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) shares are ripping higher Monday morning after the company announced positive data for its phase 2 study of
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via
Benzinga
BridgeBio Announces Positive Phase 2 Cohort 5 Results of Infigratinib in Achondroplasia Demonstrating Mean Increase in Annualized Height Velocity of 3.03 cm/year with No Treatment-related Adverse Events
March 06, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
BridgeBio to Host Investor Call to Discuss Phase 2 Cohort 5 Data for Achondroplasia on March 6, 2023
March 03, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
BridgeBio Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Business Update
February 23, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
BridgeBio Pharma to Host Educational Roundtable with Esteemed Achondroplasia Expert on February 16, 2023
February 13, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
BridgeBio Pharma to Participate in February and March Investor Events
February 08, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.